$GTCH's mobile app is planned to communicate with
Post# of 44956
(Total Views: 196)
Posted On: 10/13/2021 2:54:39 PM
$GTCH's mobile app is planned to communicate with GBT’s AI engine for intelligent health monitoring and alert capabilities
SAN DIEGO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”) is developing an iOS (iPhone version) mobile application for its qTerm device. The iOS application will be synchronized with qTerm’s website and Widget. The mobile app will establish Low Energy Bluetooth (BLE) with the device electronics and show the user vitals results upon taking measurements. A secured infrastructure for user’s privacy and confidentiality will be prepared following industry cybersecurity standards.
The application will be targeted to provide all necessary data to be transferred to an AI engine for further processing. GBT's qTerm, a human vitals device, is aimed to measure human vitals with a touch of a finger. The iOS mobile application is planned to provide real-time visual results, and at a later stage will include AI statistics and analysis. An Android version was already developed a few months ago and was used during prototype testing.
GBT plans to develop a dedicated version of its Avant! AI system to perform user’s on going vitals monitoring and analytics. The system is designed to alert in case of abnormal results, remind about medial check/follow-ups, and monitor medications. Upon taking vitals measurement, the iPhone app will present the data, with full synchronization with qTerm’s web portal, including body temperature color code visual feedback for immediate abnormality identification. The web application Widget will be supporting the iOS version to enable remote telemedicine possibilities. GBT will evaluate adding to the app vital health related information like close by clinics, urgent care sites and hospital locations. An initial version of the iOS mobile app is targeted to be complete by the end of the year.
SAN DIEGO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”) is developing an iOS (iPhone version) mobile application for its qTerm device. The iOS application will be synchronized with qTerm’s website and Widget. The mobile app will establish Low Energy Bluetooth (BLE) with the device electronics and show the user vitals results upon taking measurements. A secured infrastructure for user’s privacy and confidentiality will be prepared following industry cybersecurity standards.
The application will be targeted to provide all necessary data to be transferred to an AI engine for further processing. GBT's qTerm, a human vitals device, is aimed to measure human vitals with a touch of a finger. The iOS mobile application is planned to provide real-time visual results, and at a later stage will include AI statistics and analysis. An Android version was already developed a few months ago and was used during prototype testing.
GBT plans to develop a dedicated version of its Avant! AI system to perform user’s on going vitals monitoring and analytics. The system is designed to alert in case of abnormal results, remind about medial check/follow-ups, and monitor medications. Upon taking vitals measurement, the iPhone app will present the data, with full synchronization with qTerm’s web portal, including body temperature color code visual feedback for immediate abnormality identification. The web application Widget will be supporting the iOS version to enable remote telemedicine possibilities. GBT will evaluate adding to the app vital health related information like close by clinics, urgent care sites and hospital locations. An initial version of the iOS mobile app is targeted to be complete by the end of the year.
(0)
(0)